Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos
FORMA FARMACÉUTICA DE LIBERACIÓN PROLONGADA PARA LA ADMINISTRACIÓN INTRAUTERINA DE INTERFERÓN TAU BOVINO PARA EL CONTROL DEL CICLO REPRODUCTIVO EN VACUNOS; Y MÉTODO DE PREPARACIÓN. The present invention relates to a novel sustained-release pharmaceutical form for the intrauterine administration of b...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | FRANK CAMACHO CASANOVA NATALIE CAROLINA PARRA PEREIRA OLIBERTO SANCHEZ RAMOS OSCAR IGNACIO CABEZAS ÁVILA SEIDY PEDROSO SANTANA RAÚL ENRIQUE CASTILLO CEARDI EMILIO LAMAZARES ARCIA JORGE ROBERTO TOLEDO ALONSO |
description | FORMA FARMACÉUTICA DE LIBERACIÓN PROLONGADA PARA LA ADMINISTRACIÓN INTRAUTERINA DE INTERFERÓN TAU BOVINO PARA EL CONTROL DEL CICLO REPRODUCTIVO EN VACUNOS; Y MÉTODO DE PREPARACIÓN.
The present invention relates to a novel sustained-release pharmaceutical form for the intrauterine administration of bovine interferon tau (IFN- τ ) for controlling the reproductive cycle in cattle, which includes particles comprising bovine IFN- τ and 0.5% w/v chitosan; and a dehydrated hydrogel base comprising 8% w/v starch. The present invention also relates to a method for preparing said pharmaceutical form. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2021001591A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2021001591A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2021001591A13</originalsourceid><addsrcrecordid>eNqNiz0KwkAQhdNYiHqHAWshG7GwDMFgYWkfJpuJDGxml_2JZ7L2CLmYUbS3eT-87y2ze239gNDjrHp6pMgaoSMw3JJHzdNTwHlrrNywQ3DoEQwCdgMLh_hDWOaYInmWz33u5Hvy7y1igtaOLBZIYESdxIZ1tujRBNp8fZVt69O1Ou_I2YaCQ01CsakuRV6oPFeHoyrV_j_qBXH7SdI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos</title><source>esp@cenet</source><creator>FRANK CAMACHO CASANOVA ; NATALIE CAROLINA PARRA PEREIRA ; OLIBERTO SANCHEZ RAMOS ; OSCAR IGNACIO CABEZAS ÁVILA ; SEIDY PEDROSO SANTANA ; RAÚL ENRIQUE CASTILLO CEARDI ; EMILIO LAMAZARES ARCIA ; JORGE ROBERTO TOLEDO ALONSO</creator><creatorcontrib>FRANK CAMACHO CASANOVA ; NATALIE CAROLINA PARRA PEREIRA ; OLIBERTO SANCHEZ RAMOS ; OSCAR IGNACIO CABEZAS ÁVILA ; SEIDY PEDROSO SANTANA ; RAÚL ENRIQUE CASTILLO CEARDI ; EMILIO LAMAZARES ARCIA ; JORGE ROBERTO TOLEDO ALONSO</creatorcontrib><description>FORMA FARMACÉUTICA DE LIBERACIÓN PROLONGADA PARA LA ADMINISTRACIÓN INTRAUTERINA DE INTERFERÓN TAU BOVINO PARA EL CONTROL DEL CICLO REPRODUCTIVO EN VACUNOS; Y MÉTODO DE PREPARACIÓN.
The present invention relates to a novel sustained-release pharmaceutical form for the intrauterine administration of bovine interferon tau (IFN- τ ) for controlling the reproductive cycle in cattle, which includes particles comprising bovine IFN- τ and 0.5% w/v chitosan; and a dehydrated hydrogel base comprising 8% w/v starch. The present invention also relates to a method for preparing said pharmaceutical form.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211126&DB=EPODOC&CC=CL&NR=2021001591A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211126&DB=EPODOC&CC=CL&NR=2021001591A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRANK CAMACHO CASANOVA</creatorcontrib><creatorcontrib>NATALIE CAROLINA PARRA PEREIRA</creatorcontrib><creatorcontrib>OLIBERTO SANCHEZ RAMOS</creatorcontrib><creatorcontrib>OSCAR IGNACIO CABEZAS ÁVILA</creatorcontrib><creatorcontrib>SEIDY PEDROSO SANTANA</creatorcontrib><creatorcontrib>RAÚL ENRIQUE CASTILLO CEARDI</creatorcontrib><creatorcontrib>EMILIO LAMAZARES ARCIA</creatorcontrib><creatorcontrib>JORGE ROBERTO TOLEDO ALONSO</creatorcontrib><title>Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos</title><description>FORMA FARMACÉUTICA DE LIBERACIÓN PROLONGADA PARA LA ADMINISTRACIÓN INTRAUTERINA DE INTERFERÓN TAU BOVINO PARA EL CONTROL DEL CICLO REPRODUCTIVO EN VACUNOS; Y MÉTODO DE PREPARACIÓN.
The present invention relates to a novel sustained-release pharmaceutical form for the intrauterine administration of bovine interferon tau (IFN- τ ) for controlling the reproductive cycle in cattle, which includes particles comprising bovine IFN- τ and 0.5% w/v chitosan; and a dehydrated hydrogel base comprising 8% w/v starch. The present invention also relates to a method for preparing said pharmaceutical form.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNiz0KwkAQhdNYiHqHAWshG7GwDMFgYWkfJpuJDGxml_2JZ7L2CLmYUbS3eT-87y2ze239gNDjrHp6pMgaoSMw3JJHzdNTwHlrrNywQ3DoEQwCdgMLh_hDWOaYInmWz33u5Hvy7y1igtaOLBZIYESdxIZ1tujRBNp8fZVt69O1Ou_I2YaCQ01CsakuRV6oPFeHoyrV_j_qBXH7SdI</recordid><startdate>20211126</startdate><enddate>20211126</enddate><creator>FRANK CAMACHO CASANOVA</creator><creator>NATALIE CAROLINA PARRA PEREIRA</creator><creator>OLIBERTO SANCHEZ RAMOS</creator><creator>OSCAR IGNACIO CABEZAS ÁVILA</creator><creator>SEIDY PEDROSO SANTANA</creator><creator>RAÚL ENRIQUE CASTILLO CEARDI</creator><creator>EMILIO LAMAZARES ARCIA</creator><creator>JORGE ROBERTO TOLEDO ALONSO</creator><scope>EVB</scope></search><sort><creationdate>20211126</creationdate><title>Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos</title><author>FRANK CAMACHO CASANOVA ; NATALIE CAROLINA PARRA PEREIRA ; OLIBERTO SANCHEZ RAMOS ; OSCAR IGNACIO CABEZAS ÁVILA ; SEIDY PEDROSO SANTANA ; RAÚL ENRIQUE CASTILLO CEARDI ; EMILIO LAMAZARES ARCIA ; JORGE ROBERTO TOLEDO ALONSO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2021001591A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FRANK CAMACHO CASANOVA</creatorcontrib><creatorcontrib>NATALIE CAROLINA PARRA PEREIRA</creatorcontrib><creatorcontrib>OLIBERTO SANCHEZ RAMOS</creatorcontrib><creatorcontrib>OSCAR IGNACIO CABEZAS ÁVILA</creatorcontrib><creatorcontrib>SEIDY PEDROSO SANTANA</creatorcontrib><creatorcontrib>RAÚL ENRIQUE CASTILLO CEARDI</creatorcontrib><creatorcontrib>EMILIO LAMAZARES ARCIA</creatorcontrib><creatorcontrib>JORGE ROBERTO TOLEDO ALONSO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRANK CAMACHO CASANOVA</au><au>NATALIE CAROLINA PARRA PEREIRA</au><au>OLIBERTO SANCHEZ RAMOS</au><au>OSCAR IGNACIO CABEZAS ÁVILA</au><au>SEIDY PEDROSO SANTANA</au><au>RAÚL ENRIQUE CASTILLO CEARDI</au><au>EMILIO LAMAZARES ARCIA</au><au>JORGE ROBERTO TOLEDO ALONSO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos</title><date>2021-11-26</date><risdate>2021</risdate><abstract>FORMA FARMACÉUTICA DE LIBERACIÓN PROLONGADA PARA LA ADMINISTRACIÓN INTRAUTERINA DE INTERFERÓN TAU BOVINO PARA EL CONTROL DEL CICLO REPRODUCTIVO EN VACUNOS; Y MÉTODO DE PREPARACIÓN.
The present invention relates to a novel sustained-release pharmaceutical form for the intrauterine administration of bovine interferon tau (IFN- τ ) for controlling the reproductive cycle in cattle, which includes particles comprising bovine IFN- τ and 0.5% w/v chitosan; and a dehydrated hydrogel base comprising 8% w/v starch. The present invention also relates to a method for preparing said pharmaceutical form.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_CL2021001591A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Forma farmacéutica de liberación prolongada para la administración intrauterina de interferón tau bovino en vacunos |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T21%3A38%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRANK%20CAMACHO%20CASANOVA&rft.date=2021-11-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2021001591A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |